David A. Siegel Atossa Therapeutics, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 13,500 shares of ATOS stock, worth $13,905. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,500

Previous 54,200 75.09%

Holding current value

$13,905

Previous $64,000 68.75%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.09 - $1.52 $44,363 - $61,864	-40,700 Reduced 75.09%	13,500 $20,000
Q2 2024 Aug 14, 2024	BUY	$1.03 - $2.1 $36,771 - $74,970	35,700 Added 192.97%	54,200 $64,000
Q1 2024 May 15, 2024	SELL	$0.8 - $1.89 $5,360 - $12,663	-6,700 Reduced 26.59%	18,500 $33,000
Q4 2023 Feb 14, 2024	BUY	$0.63 - $0.98 $2,457 - $3,822	3,900 Added 18.31%	25,200 $22,000
Q3 2023 Nov 14, 2023	SELL	$0.74 - $1.35 $4,514 - $8,235	-6,100 Reduced 22.26%	21,300 $15,000
Q2 2023 Aug 14, 2023	SELL	$0.6 - $1.28 $20,040 - $42,752	-33,400 Reduced 54.93%	27,400 $34,000
Q1 2023 May 15, 2023	SELL	$0.59 - $0.91 $18,172 - $28,028	-30,800 Reduced 33.62%	60,800 $43,000
Q4 2022 Feb 14, 2023	SELL	$0.5 - $1.01 $6,900 - $13,938	-13,800 Reduced 13.09%	91,600 $48,000
Q3 2022 Nov 14, 2022	SELL	$0.82 - $1.14 $17,958 - $24,965	-21,900 Reduced 17.2%	105,400 $88,000
Q2 2022 Aug 15, 2022	SELL	$0.85 - $1.28 $471,155 - $709,504	-554,300 Reduced 81.32%	127,300 $139,000
Q1 2022 May 16, 2022	SELL	$1.11 - $1.74 $1.02 Million - $1.59 Million	-916,330 Reduced 57.34%	681,600 $852,000
Q4 2021 Feb 14, 2022	BUY	$1.6 - $3.27 $2.42 Million - $4.94 Million	1,509,930 Added 1715.83%	1,597,930 $2.56 Million
Q3 2021 Nov 15, 2021	BUY	$2.89 - $6.4 $143,055 - $316,800	49,500 Added 128.57%	88,000 $287,000
Q2 2021 Aug 16, 2021	SELL	$1.52 - $8.62 $15,048 - $85,337	-9,900 Reduced 20.45%	38,500 $243,000
Q1 2021 May 17, 2021	BUY	$0.92 - $4.33 $34,592 - $162,808	37,600 Added 348.15%	48,400 $102,000
Q4 2020 Feb 16, 2021	SELL	$0.85 - $2.43 $1,190 - $3,402	-1,400 Reduced 11.48%	10,800 $10,000
Q3 2020 Nov 16, 2020	BUY	$1.98 - $4.35 $24,156 - $53,069	12,200 New	12,200 $30,000

Others Institutions Holding ATOS

# of Institutions

Shares Held

26.5M

Call Options Held

466K

Put Options Held

91.8K

View Full List

About ATOSSA THERAPEUTICS, INC.

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $130M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

More about ATOS

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account